Vitrolife AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 905 million compared to SEK 829 million a year ago. Net income was SEK 106 million compared to SEK 130 million a year ago. Basic earnings per share from continuing operations was SEK 0.78 compared to SEK 0.96 a year ago.
For the six months, sales was SEK 1,759 million compared to SEK 1,581 million a year ago. Net income was SEK 206 million compared to SEK 212 million a year ago. Basic earnings per share from continuing operations was SEK 1.52 compared to SEK 1.56 a year ago.